Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Mild”

1,534 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,534 results

Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Not applicableStudy completedNCT03313895
What this trial is testing

The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial

Who this might be right for
Mild Cognitive Impairment
Arizona State University 146
Testing effectiveness (Phase 2)Study completedNCT05063539
What this trial is testing

LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 327
Not applicableUnknownNCT06372002
What this trial is testing

Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia

Who this might be right for
DementiaNeurocognitive DisordersMild Cognitive Impairment
Instituto de Mayores y Servicios Sociales (IMSERSO) 683
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Not applicableStudy completedNCT05803122
What this trial is testing

Validation of the I-UDS Neuropsychological Battery

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
IRCCS National Neurological Institute "C. Mondino" Foundation 252
Not applicableUnknownNCT00900770
What this trial is testing

Implications of Amyloid Pathology

Who this might be right for
Alzheimer's Disease
National Institute on Aging (NIA) 100
Testing effectiveness (Phase 2)Study completedNCT00090402
What this trial is testing

Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseOxidative StressDementia+2 more
Oregon Health and Science University 39
Early research (Phase 1)Ended earlyNCT01677572
What this trial is testing

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 197
Very early researchLooking for participantsNCT06181513
What this trial is testing

Probiotics in Mild Alzheimer's Disease

Who this might be right for
Neurodegenerative DiseasesCognition Disorders in Old Age
University of Nicosia 40
Not applicableLooking for participantsNCT05748613
What this trial is testing

Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

Who this might be right for
AnxietyMild Cognitive ImpairmentAlzheimer Disease+1 more
Florida State University 388
Not applicableStudy completedNCT01825317
What this trial is testing

Effect of NeuroAD on Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Neuronix Ltd 32
Not applicableStudy completedNCT03824197
What this trial is testing

Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)

Who this might be right for
Alzheimer DiseaseCerebral Amyloid Angiopathy
Auburn University 25
Not applicableLooking for participantsNCT02740634
What this trial is testing

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Who this might be right for
Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)+5 more
Mayo Clinic 60
Very early researchStudy completedNCT02045056
What this trial is testing

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

Who this might be right for
Preclinical Alzheimer's Disease
Gregory Jicha, 323-5550 72
Testing effectiveness (Phase 2)UnknownNCT04780399
What this trial is testing

Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseYangxue Qingnao PillsRandomized
Dongzhimen Hospital, Beijing 216
Testing effectiveness (Phase 2)UnknownNCT01120002
What this trial is testing

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Osaka City University 50
Not applicableStudy completedNCT00908999
What this trial is testing

Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Who this might be right for
AnosognosiaAlzheimer's DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 60
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Next Page